ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,377Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 2343

$1.55M Total Retail Price of All Prescriptions

Rank: 22 out of 2343

648 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 648 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 25,193 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 1,197 1,181 1 8
LEVOTHYROXINE SODIUM 983 942 2 2
METOPROLOL TARTRATE 918 894 3 7
FUROSEMIDE 906 873 4 6
SIMVASTATIN 704 677 5 1
POTASSIUM CHLORIDE 701 675 6 18
OMEPRAZOLE 534 469 7 4
NAMENDA 461 461 8 36
PANTOPRAZOLE SODIUM 429 398 9 22
DONEPEZIL HCL 429 429 9 21
ATORVASTATIN CALCIUM 427 416 11 10
LISINOPRIL 422 398 12 3
HYDROCODONE-ACETAMINOPHEN 403 364 S3 13 13
AMLODIPINE BESYLATE 358 358 14 5
ESCITALOPRAM OXALATE 332 325 15 55
AMLODIPINE BESYLATE-BENAZEPRIL 331 320 16 59
DIGOXIN 315 302 17 35
METFORMIN HCL 310 305 18 9
PREDNISONE 300 281 19 37
ATENOLOL 283 283 20 12
SERTRALINE HCL 241 232 21 20
KLOR-CON 10 227 201 22 134
CITALOPRAM HBR 224 224 23 17
IPRATROPIUM-ALBUTEROL 224 219 23 99
TRAMADOL HCL 221 213 25 25
CLOPIDOGREL 219 218 26 26
ZOLPIDEM TARTRATE 217 197 27 24
ISOSORBIDE MONONITRATE ER 216 216 28 32
LANTUS 215 209 29 51
MIRTAZAPINE 208 204 30 41
CEPHALEXIN 195 194 31 111
BUMETANIDE 193 186 32 91
METOPROLOL SUCCINATE 180 177 33 14
COUMADIN 179 179 34 216
DIOVAN 179 173 34 23
TRAZODONE HCL 177 166 36 53
NOVOLOG 171 171 37 110
FENTANYL 166 166 S2 38 69
HYDROCHLOROTHIAZIDE 160 133 39 11
BENAZEPRIL HCL 151 151 40 113
GABAPENTIN 151 139 40 16
VENLAFAXINE HCL ER 149 149 42 87
OXYCODONE-ACETAMINOPHEN 144 143 S2 43 49
ALLOPURINOL 141 141 44 31
PLAVIX 140 140 45 38
AMITIZA 139 127 46 304
CARVEDILOL 135 131 47 27
ALENDRONATE SODIUM 135 133 47 28
ZETIA 132 119 49 52
RISPERIDONE 131 129 50 61
TAMSULOSIN HCL 130 118 51 29
CARBIDOPA-LEVODOPA 125 125 52 85
LEXAPRO 125 125 52 178
NEXIUM 122 122 54 33
PRAVASTATIN SODIUM 119 111 55 15
LYRICA 117 113 56 135
SPIRIVA 116 101 57 48
CELEBREX 115 89 58 71
NYSTATIN-TRIAMCINOLONE 114 107 59 249
PHENYTOIN SODIUM EXTENDED 112 112 60 152
DETROL LA 108 91 61 150
PROCRIT 102 102 62 306
SYNTHROID 96 96 63 40
GLIMEPIRIDE 92 92 64 45
METOCLOPRAMIDE HCL 87 80 65 168
EXELON 85 85 66 129
ADVAIR DISKUS 84 80 67 34
LACTULOSE 84 81 67 139
LEVETIRACETAM 82 82 69 104
JANUVIA 82 82 69 50
FAMOTIDINE 81 80 71 60
QUETIAPINE FUMARATE 80 78 72 77
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 76 73 120
CLONIDINE HCL 77 77 74 70
PAROXETINE HCL 75 72 75 66
AZITHROMYCIN 72 65 76 39
POLYETHYLENE GLYCOL 3350 72 72 76 54
DIOVAN HCT 72 72 76 63
PROCHLORPERAZINE MALEATE 71 67 79 287
ENALAPRIL MALEATE 70 70 80 58
DIPHENOXYLATE-ATROPINE 70 64 80 329
GLIPIZIDE 69 67 82 56
PRAMIPEXOLE DIHYDROCHLORIDE 69 69 82 187
SPIRONOLACTONE 69 63 82 65
QUINAPRIL HCL 68 68 85 73
PROPRANOLOL HCL 68 68 85 132
APIDRA 67 67 87 524
LEVOFLOXACIN 67 64 87 106
ENOXAPARIN SODIUM 66 61 89 203
AGGRENOX 65 65 90 174
FLUOXETINE HCL 64 47 91 82
LIPITOR 64 63 91 78
KLOR-CON M10 64 64 91 107
GEMFIBROZIL 63 39 94 133
CIPROFLOXACIN HCL 61 60 95 72
KLOR-CON M20 61 61 95 44
HALOPERIDOL 60 60 97 229
BYSTOLIC 59 59 98 123
CHOLESTYRAMINE 59 58 98 484
FLUOCINONIDE 58 47 100 256
TIZANIDINE HCL 58 51 100 296
LOPERAMIDE 57 48 102 238
OXYCONTIN 57 57 S2 102 138
ZOSTAVAX 56 55 104 236
METOLAZONE 56 56 104 173
LOSARTAN POTASSIUM 55 55 106 19
NOVOLIN R 55 55 106 227
CRESTOR 54 51 108 30
NITROGLYCERIN PATCH 54 54 108 147
TRIAMCINOLONE ACETONIDE 54 54 108 137
AMOX TR-POTASSIUM CLAVULANATE 53 48 111 160
ABILIFY 53 53 111 159
MORPHINE SULFATE ER 53 53 S2 111 142
ADVAIR HFA 53 47 111 376
DILTIAZEM 24HR CD 53 53 111 83
RANITIDINE HCL 50 45 116 43
PREVACID 50 50 116 379
GLYBURIDE 50 50 R 116 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.